Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
Donne
A
A
Rothera
M
M
Homer
J
J
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D036502:Infusions, Intralesional; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D010212:Papilloma / Q000150:complications* / Q000188:drug therapy*; D012008:Recurrence; D012120:Respiration Disorders / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D012720:Severity of Illness Index
D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir